Long-term effects of medical and surgical treatments on Parkinson's disease

Stereotact Funct Neurosurg. 1994;62(1-4):85-9. doi: 10.1159/000098601.

Abstract

Three groups of patients with Parkinson's disease (PD) were studied: (1) PD patients treated medically with L-Dopa and anticholinergics, (2) PD patients treated with thalamo-subthalamotomies plus medical treatment, and (3) PD patients treated with autologous adrenal medullary transplantation to right caudate nucleus plus medical treatment. Evaluations prior and 1, 6 and 12 months after treatment were accomplished with PD scales (NYPDS, UPDS, Schwab and England and Hoehn and Yahr scales). No attempt was made to compare one PD after treatment in each group. Statistical analysis was performed with the Friedman-Anova test. Group 1 did not show significant improvement at any time but deterioration at 12 months. Group 2 showed significant improvement at 1 month but at 12 months deterioration occurred mainly in the mental condition and akinesia. Group 3 did not show significant improvement at any time but at 12 months there was a tendency of improvement in self-sufficiency.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adrenal Medulla / transplantation*
  • Adult
  • Aged
  • Analysis of Variance
  • Caudate Nucleus
  • Cholinergic Antagonists / therapeutic use*
  • Combined Modality Therapy
  • Follow-Up Studies
  • Humans
  • Levodopa / therapeutic use*
  • Middle Aged
  • Parkinson Disease / surgery
  • Parkinson Disease / therapy*
  • Prospective Studies
  • Thalamus / surgery*

Substances

  • Cholinergic Antagonists
  • Levodopa